Trials / Completed
CompletedNCT00945555
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Multi-Center, Non-Interventional, Observational Study To Evaluate The Antibacterial Therapeutical Options In Febrile Neutropenia Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to define and classify antibacterial agents used in Turkey for patients with febrile neutropenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antibacterial agent for the treatment of febrile neutropenia | The antibacterial agent used by the investigators for febrile neutropenia will be determined and classified in the preference order |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-07-24
- Last updated
- 2017-04-05
- Results posted
- 2011-11-03
Locations
5 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00945555. Inclusion in this directory is not an endorsement.